CPDA-1 155 mg/70mL (Anticoagulant Citrate Phosphate Dextrose Adenine SOLUTION) 155 mg/70mL

CPDA-1 155 mg/70mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, designed for medical use.

Strength

155 mg/70mL

Pack Size

70 mL in 1 BAG (0942-6312-04)

Manufacturer / TM Owner

Fenwal, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CPDA-1 155 mg/70mL is primarily used to prevent blood clotting during storage. This solution is often utilized in blood banks and medical facilities to extend the shelf life of stored blood. It is commonly asked, 'What is CPDA-1 used for?' The primary function is to maintain the quality and viability of blood components for transfusion purposes.

Side Effects

When administered intravenously, CPDA-1 155 mg/70mL helps to keep blood in a stable state. It works by inhibiting the clotting process, allowing blood to be stored for longer periods. Users may notice that the solution helps maintain the integrity of blood components during storage.

Precautions & Warnings

Handling CPDA-1 155 mg/70mL requires careful attention to sterile techniques. It should be stored and used in accordance with medical guidelines to ensure safety. Always check the solution for any signs of contamination before use.

Avoid Interactions

CPDA-1 155 mg/70mL may interact with certain medications or substances. It is important to consult with a healthcare provider before using this solution, especially if other medications are being taken. Always follow the recommended guidelines for administration to avoid potential interactions.

Frequently Asked Questions

CPDA-1 155 mg/70mL is used to prevent blood clotting during storage, extending the shelf life of blood components.

CPDA-1 155 mg/70mL should be stored in a cool, dry place away from direct sunlight and contamination.

It is important to consult with a healthcare provider before using CPDA-1 155 mg/70mL with other medications to avoid potential interactions.

CPDA-1 155 mg/70mL helps to maintain the stability of blood components by inhibiting clotting during storage.

Safety can vary; always consult with a healthcare provider before use, especially if there are pre-existing conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.